• Audits of oncology units – an effective and pragmatic approach 

      Abratt, R. P.; Eedes, D.; Bailey, B.; Salmon, C.; Govender, Y.; Oelofse, I.; Burger, H. (Health and Medical Publishing Group, 2017)
      Background. Audits of oncology units are part of all quality-assurance programmes. However, they do not always come across as pragmatic and helpful to staff. Objective. To report on the results of an online survey on ...
    • Automated treatment planning of postmastectomy radiotherapy 

      Kisling, Kelly; Zhang, Lifei; Shaitelman, Simona F.; Anderson, David; Thebe, Tselane; Yang, Jinzhong; Balter, Peter A.; Howell, Rebecca M.; Jhingran, Anuja; Schmeler, Kathleen; Simonds, Hannah; Du Toit, Monique; Trauernicht, Christoph; Burger, Hester; Botha, Kobus; Joubert, Nanette; Beadle, Beth M.; Court, Laurence (American Association of Physicists in Medicine, 2019-05-11)
      Purpose: Breast cancer is the most common cancer in women globally and radiation therapy is a cornerstone of its treatment. However, there is an enormous shortage of radiotherapy staff, especially in low- and middle-income ...
    • Chemotherapy administration standards and guidelines : the development of a resource document 

      Eedes, David J.; Bailey, Belinda; Burger, Henriette (AOSIS, 2018-08-13)
      There are no nationally recognised guidelines for the handling and administration of chemotherapy in South Africa. The Independent Clinical Oncology Network’s Chemotherapy Administration Standards and Guidelines Resource ...
    • Establishing a multidisciplinary AIDS-associated Kaposi’s sarcoma clinic : patient characteristics, management and outcomes 

      Burger, H.; Ismail, Z.; Taljaard, J. J. (Health & Medical Publishing Group, 2018-12)
      Background: Kaposi’s sarcoma (KS) typically occurs in the setting of immunodeficiency and specifically in the presence of HIV infection, when it is called AIDS-associated KS (AIDS-KS). In spite of impressive gains in the ...
    • Fully automatic treatment planning for external-beam radiation therapy of locally advanced cervical cancer : a tool for low-resource clinics 

      Kisling, Kelly; Zhang, Lifei; Simonds, Hannah M.; Fakie, Nazia; Yang, Jinzhong; McCarroll, Rachel; Balter, Peter; Burger, Hester; Bogler, Oliver; Howell, Rebecca; Schmeler, Kathleen; Mejia, Mike; Beadle, Beth M.; Jhingran, Anuja; Court, Laurence (American Society of Clinical Oncology, 2019)
      PURPOSE: The purpose of this study was to validate a fully automatic treatment planning system for conventional radiotherapy of cervical cancer. This system was developed to mitigate staff shortages in low-resource ...
    • Gestational trophoblastic neoplasm and women living with HIV and/or AIDS 

      Barnardt, Pieter; Relling, Martha (AOSIS Publishing, 2015-07-03)
      The 2011 World Health Organization global report on HIV and/or AIDS estimated that sub-Saharan Africa comprised 67% of the global HIV burden, with a current estimate of 5.9 million cases in South Africa. Since the introduction ...
    • Hypofractionation and prostate cancer : a good option for Africa? 

      Incrocci, Luca; Heijmen, Ben; Kupelian, Patrick; Simonds, Hannah M. (AOSIS, 2017-08-29)
      Cancer is an emerging public health problem in Africa. According to the World Health Organization, the numbers will be doubled by 2030 because of the ageing and the growth of the population. Prostate cancer is the most ...
    • Long-term complications of pelvic radiotherapy 

      Simonds, Hannah (South African Society of Gynaecologic Oncology, 2010)
      Complications following pelvic radiation are frequently under-reported and inadequately addressed. This overview examines the nature and the intensity of complications encountered by cancer survivors; it focuses specifically ...
    • Malignant peripheral nerve sheath tumours and neurofibromatosis 1 : a case series and recommendations for care 

      Burger, Henriette; Bezuidenhout, Heidre; Sher-Locketz, Candice; Baatjes, Karin; Van Wyk, Jacques; Bonthuys, Anita (AOSIS, 2018-08-20)
      Background: The incidence of malignant peripheral nerve sheath tumours (MPNST) in patients with neurofibromatosis 1 (NF1) is significantly higher than that of the general population. NF1-associated MPNST occur at a younger ...
    • Managing AIDS-related Kaposi’s sarcoma and pregnancy 

      Barnardt, Pieter (AOSIS Publishing, 2013-05)
      An estimated 30 - 40% of HIV-infected patients are likely to develop cancer during the progression of their disease. The occurrence of malignancy among these patients represents a difficult challenge in their care. Kaposi’s ...
    • Managing gestational trophoblastic neoplasm (GTN) and people living with HIV (PLWH) 

      Barnardt, Pieter (MedPharm Publications, 2019)
      The 2017 World Health Organization (WHO) global report on HIV/AIDS estimated that sub-Saharan Africa comprised 64% of the global HIV burden, with a current estimate of 19.4 million cases in Eastern and Southern Africa. ...
    • Medical students' perceptions on euthanasia and physician-assisted suicide : are they fully informed? 

      Burger, H.; Gwyther, L.; Krause, R.; Ratshikana-Moloko, M.; Hellenberg, D. (Health & Medical Publishing Group, 2018)
      No abstract available
    • Morphine and chronic cancer pain 

      Smit, B. J. (Health & Medical Publishing Group, 2001-10)
      Cancer pain can be broken down into the following categories: (i),pain caused by the cancer process itself, i.e. bony invasion or nerve compression or infiltration that is likely to present with the features of acute pain; ...
    • Morphine for cancer pain 

      Smit, B. J. (Health & Medical Publishing Group, 1994)
      [No abstract available]
    • Neutron radiotherapy in South Africa : neutron radiotherapy should continue 

      Sauerwein, Wolfgang; Engenhart-Cabillic, Rita; Forman, Jeffrey D.; Gueulette, John; Hachem, Sabet; Jones, Dan; Krull, Andreas; Lukas, Peter; Mandrillon, Pierre; Petry, Winfried; Rosenberg, Ivan; Venimmen, Frederik; Welsh, James S. (Health and Medical Publishing Group (HMPG), 2012-04)
      To the Editor: Abratt’s letter needs a response. We are currently – or have been directly – involved in treating patients with fast neutrons for decades; some with more than 20 years’ experience in proton therapy, and ...
    • Ovarian germ cell tumour and bleomycin-induced lung injury 

      Barnardt, Pieter; Griffith-Richards, Stephanie (Medpharm Publications, 2018)
      Bleomycin, an antibiotic agent with antitumour activity, is an important drug in the management of many oncological malignancies such as lymphoma and germ cell tumours. These tumours are potentially curable and mostly ...
    • Pentastomiasis (armillifer armillatus infestation) 

      Du Plessis, Vicci; Birnie, Andrew J.; Eloff, Ivor; Reuter, Helmuth; Andronikou, Savvas (Health and Medical Publishing Group (HMPG), 2007-10)
      Pentastomiasis, also known as ‘tongue worm’ infestation or porocephalosis, is a parasitic zoonosis endemic to western and central Africa. In 1847, Pruner described the first human infection by a pentastomid in Cairo. ...
    • A phase I trial of hypoxoside as an oral prodrug for cancer therapy : absence of toxicity 

      Smit, B. J.; Albrecht, C. F.; Liebenberg, R. W.; Kruger, P. B.; Freestone, M.; Gouws, L.; Theron, E.; Bouic, P. J. D.; Etsebeth, S.; Van Jaarsveld, P. P. (Health & Medical Publishing Group, 1995)
      Objective. To assess the toxicity of hypoxoside taken orally by 24 patients with lung cancer. Design. Open study with patients taking 1 200 - 3 200 mg standardised Hypoxis plant extract (200 mg capsules) per day divided ...
    • Photosensitizers and radiosensitizers in dermatology and oncology 

      Bruckner, V. (HMPG, 1979-09)
      Two therapeutic modalities are currently of great interest, namely photo- and radiosensitization. Whereas photosensitizers only function in combination with ultraviolet (UV) light, radiosensitizers act only in combination ...
    • Plasma sarcosine does not distinguish early and advanced stages of prostate cancer 

      Bohm, L.; Serafin, A. M.; Fernandez, P.; Van der Watt, G.; Bouic, P. J. D.; Harvey, J. (Health and Medical Publishing Group (HMPG), 2012-08)
      Introduction. Diagnosis of prostate cancer by prostate specific antigen (PSA) is error-prone and cannot distinguish benign prostatic hyperplasia (BPH) from malignant disease, nor identify aggressive and indolent types. ...